

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | protein heterotrimerization (GO:0070208) | 5.60869039 |
| 2 | type B pancreatic cell proliferation (GO:0044342) | 5.04058926 |
| 3 | extracellular fibril organization (GO:0043206) | 4.47741158 |
| 4 | synaptic vesicle exocytosis (GO:0016079) | 4.36846657 |
| 5 | collagen fibril organization (GO:0030199) | 4.34198916 |
| 6 | cell migration involved in heart development (GO:0060973) | 4.33970483 |
| 7 | regulation of cellular response to vascular endothelial growth factor stimulus (GO:1902547) | 4.32583776 |
| 8 | regulation of vascular endothelial growth factor signaling pathway (GO:1900746) | 4.22227805 |
| 9 | skin morphogenesis (GO:0043589) | 4.20101124 |
| 10 | neuronal action potential propagation (GO:0019227) | 4.17670823 |
| 11 | adhesion of symbiont to host cell (GO:0044650) | 4.17485355 |
| 12 | virion attachment to host cell (GO:0019062) | 4.17485355 |
| 13 | keratan sulfate catabolic process (GO:0042340) | 4.15729520 |
| 14 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.14747976 |
| 15 | protein retention in ER lumen (GO:0006621) | 4.06607596 |
| 16 | kidney mesenchyme development (GO:0072074) | 4.02142167 |
| 17 | extracellular matrix assembly (GO:0085029) | 3.98210753 |
| 18 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 3.85855699 |
| 19 | sequestering of extracellular ligand from receptor (GO:0035581) | 3.85238180 |
| 20 | synaptic vesicle maturation (GO:0016188) | 3.83932172 |
| 21 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 3.83800912 |
| 22 | fibril organization (GO:0097435) | 3.82108238 |
| 23 | regulation of integrin-mediated signaling pathway (GO:2001044) | 3.78582591 |
| 24 | metanephric mesenchyme development (GO:0072075) | 3.72397762 |
| 25 | vocalization behavior (GO:0071625) | 3.66653154 |
| 26 | neuron cell-cell adhesion (GO:0007158) | 3.63695413 |
| 27 | regulation of synaptic vesicle exocytosis (GO:2000300) | 3.53218587 |
| 28 | glutamate secretion (GO:0014047) | 3.49796848 |
| 29 | adhesion of symbiont to host (GO:0044406) | 3.49089553 |
| 30 | COPI coating of Golgi vesicle (GO:0048205) | 3.44675091 |
| 31 | Golgi transport vesicle coating (GO:0048200) | 3.44675091 |
| 32 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.41654883 |
| 33 | detection of calcium ion (GO:0005513) | 3.32441531 |
| 34 | neurotransmitter secretion (GO:0007269) | 3.28927085 |
| 35 | tooth mineralization (GO:0034505) | 3.26718440 |
| 36 | locomotory exploration behavior (GO:0035641) | 3.25554308 |
| 37 | mesenchymal-epithelial cell signaling (GO:0060638) | 3.24598098 |
| 38 | cellular response to zinc ion (GO:0071294) | 3.21371297 |
| 39 | regulation of extracellular matrix disassembly (GO:0010715) | 3.19646202 |
| 40 | chondrocyte proliferation (GO:0035988) | 3.18386532 |
| 41 | endocardial cushion development (GO:0003197) | 3.14514100 |
| 42 | protein localization to synapse (GO:0035418) | 3.13135007 |
| 43 | neuromuscular process controlling posture (GO:0050884) | 3.12788674 |
| 44 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.12573616 |
| 45 | GDP-mannose metabolic process (GO:0019673) | 3.10768260 |
| 46 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 3.09726801 |
| 47 | presynaptic membrane assembly (GO:0097105) | 3.07745067 |
| 48 | presynaptic membrane organization (GO:0097090) | 3.07723221 |
| 49 | bone trabecula formation (GO:0060346) | 3.05427787 |
| 50 | postsynaptic membrane organization (GO:0001941) | 3.05154993 |
| 51 | endodermal cell differentiation (GO:0035987) | 3.03215012 |
| 52 | regulation of metalloenzyme activity (GO:0048552) | 3.02925296 |
| 53 | middle ear morphogenesis (GO:0042474) | 3.02206732 |
| 54 | barbed-end actin filament capping (GO:0051016) | 3.01414622 |
| 55 | regulation of synaptic vesicle transport (GO:1902803) | 2.97639724 |
| 56 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.97466668 |
| 57 | synaptic transmission, glutamatergic (GO:0035249) | 2.94426417 |
| 58 | response to redox state (GO:0051775) | 2.93433769 |
| 59 | neuron-neuron synaptic transmission (GO:0007270) | 2.92995894 |
| 60 | axon ensheathment in central nervous system (GO:0032291) | 2.92472516 |
| 61 | central nervous system myelination (GO:0022010) | 2.92472516 |
| 62 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 2.91503174 |
| 63 | blood vessel maturation (GO:0001955) | 2.91065793 |
| 64 | cellular response to vitamin (GO:0071295) | 2.91028439 |
| 65 | extracellular regulation of signal transduction (GO:1900115) | 2.89745934 |
| 66 | extracellular negative regulation of signal transduction (GO:1900116) | 2.89745934 |
| 67 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 2.89687531 |
| 68 | peptidyl-proline hydroxylation (GO:0019511) | 2.88942552 |
| 69 | regulation of vesicle fusion (GO:0031338) | 2.86990001 |
| 70 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.84882105 |
| 71 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.83180970 |
| 72 | cerebellar Purkinje cell differentiation (GO:0021702) | 2.82809293 |
| 73 | protein localization to cilium (GO:0061512) | 2.81665984 |
| 74 | neurotransmitter transport (GO:0006836) | 2.81043600 |
| 75 | cartilage development involved in endochondral bone morphogenesis (GO:0060351) | 2.80376953 |
| 76 | smooth muscle tissue development (GO:0048745) | 2.79677541 |
| 77 | vascular endothelial growth factor signaling pathway (GO:0038084) | 2.78331888 |
| 78 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.78300020 |
| 79 | collagen metabolic process (GO:0032963) | 2.77437957 |
| 80 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 2.77277414 |
| 81 | glutamate receptor signaling pathway (GO:0007215) | 2.76559357 |
| 82 | regulation of apoptotic process involved in morphogenesis (GO:1902337) | 2.76245361 |
| 83 | regulation of glutamate receptor signaling pathway (GO:1900449) | 2.75926867 |
| 84 | energy coupled proton transmembrane transport, against electrochemical gradient (GO:0015988) | 2.75522964 |
| 85 | ATP hydrolysis coupled proton transport (GO:0015991) | 2.75522964 |
| 86 | transmission of nerve impulse (GO:0019226) | 2.75507819 |
| 87 | negative regulation of endoplasmic reticulum calcium ion concentration (GO:0032471) | 2.74852435 |
| 88 | regulation of neuronal synaptic plasticity (GO:0048168) | 2.74719865 |
| 89 | lung vasculature development (GO:0060426) | 2.72802956 |
| 90 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.71906121 |
| 91 | negative regulation of cation channel activity (GO:2001258) | 2.71870539 |
| 92 | gamma-aminobutyric acid transport (GO:0015812) | 2.71691664 |
| 93 | basement membrane organization (GO:0071711) | 2.71362537 |
| 94 | negative regulation of microtubule polymerization (GO:0031115) | 2.71077364 |
| 95 | regulation of plasminogen activation (GO:0010755) | 2.70937989 |
| 96 | protein hydroxylation (GO:0018126) | 2.70691250 |
| 97 | regulation of synapse structural plasticity (GO:0051823) | 2.68708061 |
| 98 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.68039271 |
| 99 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 2.68026270 |
| 100 | negative regulation of phosphatidylinositol 3-kinase signaling (GO:0014067) | 2.67799577 |
| 101 | respiratory electron transport chain (GO:0022904) | 2.67591667 |
| 102 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.67083820 |
| 103 | neuromuscular synaptic transmission (GO:0007274) | 2.66904396 |
| 104 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.66671212 |
| 105 | collagen catabolic process (GO:0030574) | 2.66188610 |
| 106 | electron transport chain (GO:0022900) | 2.66140069 |
| 107 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.65492294 |
| 108 | exploration behavior (GO:0035640) | 2.64884899 |
| 109 | neuron recognition (GO:0008038) | 2.64789848 |
| 110 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.64722224 |
| 111 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.63157578 |
| 112 | ATP synthesis coupled proton transport (GO:0015986) | 2.63157578 |
| 113 | dermatan sulfate biosynthetic process (GO:0030208) | 2.62186605 |
| 114 | dermatan sulfate metabolic process (GO:0030205) | 2.61799022 |
| 115 | negative regulation of nitric-oxide synthase activity (GO:0051001) | 2.60552527 |
| 116 | response to gravity (GO:0009629) | 2.60107586 |
| 117 | adult walking behavior (GO:0007628) | 2.60016039 |
| 118 | cerebellar granule cell differentiation (GO:0021707) | 2.58108057 |
| 119 | actin filament depolymerization (GO:0030042) | 2.57867592 |
| 120 | mating behavior (GO:0007617) | 2.57038098 |
| 121 | negative regulation of smooth muscle cell migration (GO:0014912) | 2.56617607 |
| 122 | multicellular organismal macromolecule metabolic process (GO:0044259) | 2.56140307 |
| 123 | protein maturation by protein folding (GO:0022417) | 2.55783431 |
| 124 | cerebellar Purkinje cell layer development (GO:0021680) | 2.55653020 |
| 125 | regulation of neurotransmitter levels (GO:0001505) | 2.55457778 |
| 126 | glomerular basement membrane development (GO:0032836) | 2.54927136 |
| 127 | long-term synaptic potentiation (GO:0060291) | 2.54717350 |
| 128 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 2.54690020 |
| 129 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 2.54684901 |
| 130 | transferrin transport (GO:0033572) | 2.54394946 |
| 131 | extracellular matrix organization (GO:0030198) | 2.54247070 |
| 132 | extracellular structure organization (GO:0043062) | 2.53261271 |
| 133 | extracellular matrix disassembly (GO:0022617) | 2.52915888 |
| 134 | neuronal action potential (GO:0019228) | 2.52015687 |
| 135 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan (GO:0019800) | 2.50257335 |
| 136 | neuronal ion channel clustering (GO:0045161) | 2.49989369 |
| 137 | behavioral response to cocaine (GO:0048148) | 2.49578897 |
| 138 | multicellular organismal catabolic process (GO:0044243) | 2.49473422 |
| 139 | synapse assembly (GO:0007416) | 2.49420879 |
| 140 | synaptic vesicle endocytosis (GO:0048488) | 2.49324195 |
| 141 | regulation of amyloid precursor protein catabolic process (GO:1902991) | 2.49240188 |
| 142 | membrane depolarization during action potential (GO:0086010) | 2.48692736 |
| 143 | negative regulation of neurotransmitter transport (GO:0051589) | 2.48633600 |
| 144 | regulation of neurotransmitter secretion (GO:0046928) | 2.48207794 |
| 145 | cell communication by electrical coupling (GO:0010644) | 2.47833125 |
| 146 | multicellular organismal metabolic process (GO:0044236) | 2.47807001 |
| 147 | positive regulation of synapse assembly (GO:0051965) | 2.47473002 |
| 148 | female mating behavior (GO:0060180) | 2.47351236 |
| 149 | endothelial cell morphogenesis (GO:0001886) | 2.47164931 |
| 150 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.46915041 |
| 151 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.46915041 |
| 152 | positive regulation of receptor recycling (GO:0001921) | 2.46709961 |
| 153 | calcium ion-dependent exocytosis (GO:0017156) | 2.46682827 |
| 154 | activation of protein kinase A activity (GO:0034199) | 2.46140137 |
| 155 | positive regulation of pseudopodium assembly (GO:0031274) | 2.45391445 |
| 156 | response to pheromone (GO:0019236) | 2.43385878 |
| 157 | positive regulation of membrane potential (GO:0045838) | 2.43230676 |
| 158 | cellular potassium ion homeostasis (GO:0030007) | 2.42914501 |
| 159 | outer ear morphogenesis (GO:0042473) | 2.42886725 |
| 160 | synaptic vesicle transport (GO:0048489) | 2.42745863 |
| 161 | establishment of synaptic vesicle localization (GO:0097480) | 2.42745863 |
| 162 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 2.41783734 |
| 163 | synaptic transmission (GO:0007268) | 2.40111934 |
| 164 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 2.38861852 |
| 165 | layer formation in cerebral cortex (GO:0021819) | 2.38368094 |
| 166 | ferric iron transport (GO:0015682) | 2.38281277 |
| 167 | trivalent inorganic cation transport (GO:0072512) | 2.38281277 |
| 168 | regulation of neurotransmitter transport (GO:0051588) | 2.37657219 |
| 169 | positive regulation of potassium ion transport (GO:0043268) | 2.37288179 |
| 170 | nucleotide-sugar biosynthetic process (GO:0009226) | 2.36730923 |
| 171 | regulation of calcium ion-dependent exocytosis (GO:0017158) | 2.36597610 |
| 172 | cell differentiation in hindbrain (GO:0021533) | 2.36575595 |
| 173 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.36197262 |
| 174 | adrenal gland development (GO:0030325) | 2.35500810 |
| 175 | negative regulation of pathway-restricted SMAD protein phosphorylation (GO:0060394) | 2.34380113 |
| 176 | positive regulation of fibroblast migration (GO:0010763) | 2.33542722 |
| 177 | positive regulation of protein targeting to membrane (GO:0090314) | 2.30860641 |
| 178 | apoptotic cell clearance (GO:0043277) | 2.30295412 |
| 179 | COPII vesicle coating (GO:0048208) | 2.27823171 |
| 180 | response to copper ion (GO:0046688) | 2.27421864 |
| 181 | cellular response to cadmium ion (GO:0071276) | 2.27337982 |
| 182 | muscle cell migration (GO:0014812) | 2.25652819 |
| 183 | regulation of collagen metabolic process (GO:0010712) | 2.24477156 |
| 184 | negative regulation of leukocyte chemotaxis (GO:0002689) | 2.24317707 |
| 185 | negative regulation of chondrocyte differentiation (GO:0032331) | 2.22567027 |
| 186 | cellular response to amino acid stimulus (GO:0071230) | 2.22061505 |
| 187 | substrate adhesion-dependent cell spreading (GO:0034446) | 2.19908521 |
| 188 | embryonic skeletal joint morphogenesis (GO:0060272) | 2.19583007 |
| 189 | positive regulation of actin filament depolymerization (GO:0030836) | 2.19471058 |
| 190 | positive regulation of blood vessel endothelial cell migration (GO:0043536) | 2.19068926 |
| 191 | endoplasmic reticulum calcium ion homeostasis (GO:0032469) | 2.17357973 |
| 192 | vascular endothelial growth factor receptor signaling pathway (GO:0048010) | 2.16921548 |
| 193 | 4-hydroxyproline metabolic process (GO:0019471) | 2.16294183 |
| 194 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.16227898 |
| 195 | positive regulation of cartilage development (GO:0061036) | 2.15823107 |
| 196 | negative regulation of BMP signaling pathway (GO:0030514) | 2.14100519 |
| 197 | regulation of pseudopodium assembly (GO:0031272) | 2.14075562 |
| 198 | retrograde vesicle-mediated transport, Golgi to ER (GO:0006890) | 2.13755665 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 5.46367179 |
| 2 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 5.35479504 |
| 3 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 3.19650049 |
| 4 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 3.09440019 |
| 5 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 3.09080881 |
| 6 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.02166563 |
| 7 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.86152401 |
| 8 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.78607092 |
| 9 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.78607092 |
| 10 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.76432852 |
| 11 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 2.76315607 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.73485385 |
| 13 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.65089429 |
| 14 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 2.61682281 |
| 15 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.59551707 |
| 16 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.55925705 |
| 17 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.51669362 |
| 18 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.50684955 |
| 19 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.42713255 |
| 20 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 2.40043121 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 2.37627625 |
| 22 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.37023879 |
| 23 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.31602296 |
| 24 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.20734349 |
| 25 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 2.15594938 |
| 26 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.13711117 |
| 27 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 2.11017169 |
| 28 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.08732718 |
| 29 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 2.05786453 |
| 30 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 2.00198216 |
| 31 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.98329838 |
| 32 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.98079422 |
| 33 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.94389110 |
| 34 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.92133642 |
| 35 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.90313850 |
| 36 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 1.89595866 |
| 37 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.87920612 |
| 38 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.84322920 |
| 39 | CJUN_26792858_Chip-Seq_BT549_Human | 1.77866397 |
| 40 | * SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.75771052 |
| 41 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.74444928 |
| 42 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.73697610 |
| 43 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.72804095 |
| 44 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.72266962 |
| 45 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.68575226 |
| 46 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.67694709 |
| 47 | CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.67094955 |
| 48 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.63276091 |
| 49 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.62934785 |
| 50 | * SMC1_22415368_ChIP-Seq_MEFs_Mouse | 1.59700028 |
| 51 | * RAD21_21589869_ChIP-Seq_MESCs_Mouse | 1.53408538 |
| 52 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.52374854 |
| 53 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.51773779 |
| 54 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 1.51549575 |
| 55 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.50424622 |
| 56 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.49872816 |
| 57 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.49496623 |
| 58 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.49472653 |
| 59 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.49316572 |
| 60 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.42592906 |
| 61 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.41952917 |
| 62 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.40353467 |
| 63 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.39598671 |
| 64 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.38432978 |
| 65 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.38216933 |
| 66 | * TET1_21451524_ChIP-Seq_MESCs_Mouse | 1.37871606 |
| 67 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.37179738 |
| 68 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.36514400 |
| 69 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.35815402 |
| 70 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.35394851 |
| 71 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.34957864 |
| 72 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.32895745 |
| 73 | * SA1_22415368_ChIP-Seq_MEFs_Mouse | 1.32046718 |
| 74 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.31877020 |
| 75 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.31730644 |
| 76 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 1.30379659 |
| 77 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.29937601 |
| 78 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.29689156 |
| 79 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.28893106 |
| 80 | * TP53_22127205_ChIP-Seq_IMR90_Human | 1.28367861 |
| 81 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.27710231 |
| 82 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.26478373 |
| 83 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.25179156 |
| 84 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.24715253 |
| 85 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.24033711 |
| 86 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.23627899 |
| 87 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.22406375 |
| 88 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.22384206 |
| 89 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.17596744 |
| 90 | CTNNB1_20615089_ChIP-ChIP_FETAL_BRAIN_Human | 1.17109012 |
| 91 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.16800684 |
| 92 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.15758788 |
| 93 | P300_19829295_ChIP-Seq_ESCs_Human | 1.14659467 |
| 94 | OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.13855797 |
| 95 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.13733615 |
| 96 | ATF3_27146783_Chip-Seq_COLON_Human | 1.13319251 |
| 97 | CSB_26484114_Chip-Seq_FIBROBLAST_Human | 1.10496774 |
| 98 | * TP53_23651856_ChIP-Seq_MEFs_Mouse | 1.10491806 |
| 99 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.08975262 |
| 100 | OLIG2_26023283_ChIP-Seq_AINV15_Mouse | 1.07296018 |
| 101 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.05539259 |
| 102 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 1.05467239 |
| 103 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 1.04930900 |
| 104 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.03927316 |
| 105 | RING1B_27294783_Chip-Seq_NPCs_Mouse | 1.03427247 |
| 106 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.03404614 |
| 107 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.02595179 |
| 108 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.01860468 |
| 109 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.01703493 |
| 110 | SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.01461900 |
| 111 | VDR_22108803_ChIP-Seq_LS180_Human | 1.00995381 |
| 112 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.00224772 |
| 113 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.98649270 |
| 114 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 0.98427607 |
| 115 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 0.97013198 |
| 116 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.96805559 |
| 117 | CRX_20693478_ChIP-Seq_ADULT_RETINA_Mouse | 0.96654416 |
| 118 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 0.95869532 |
| 119 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 0.95447281 |
| 120 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 0.95220363 |
| 121 | P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.95081033 |
| 122 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.93773742 |
| 123 | CTCF_20526341_ChIP-Seq_ESCs_Human | 0.93689436 |
| 124 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.93653130 |
| 125 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.93653130 |
| 126 | * RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.92386466 |
| 127 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.92304311 |
| 128 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.92304311 |
| 129 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.91919711 |
| 130 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.91161501 |
| 131 | ZNF263_19887448_ChIP-Seq_K562_Human | 0.90237152 |
| 132 | AHR_22903824_ChIP-Seq_MCF-7_Human | 0.88404761 |
| 133 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.88203238 |
| 134 | TP63_22573176_ChIP-Seq_HFKS_Human | 0.87711737 |
| 135 | TET1_21490601_ChIP-Seq_MESCs_Mouse | 0.87531938 |
| 136 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.87264515 |
| 137 | ER_23166858_ChIP-Seq_MCF-7_Human | 0.86876179 |
| 138 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.86476933 |
| 139 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 0.86452871 |
| 140 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 0.86452250 |
| 141 | EOMES_21245162_ChIP-Seq_HESCs_Human | 0.86176126 |
| 142 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.85822467 |
| 143 | KLF4_18358816_ChIP-ChIP_MESCs_Mouse | 0.85626097 |
| 144 | AR_25329375_ChIP-Seq_VCAP_Human | 0.85560350 |
| 145 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.85367309 |
| 146 | SETDB1_19884255_ChIP-Seq_MESCs_Mouse | 0.84636015 |
| 147 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.84593391 |
| 148 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.83174465 |
| 149 | CTCF_27219007_Chip-Seq_Bcells_Human | 0.82846661 |
| 150 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.82841011 |
| 151 | FOXP2_21765815_ChIP-ChIP_NEURO2A_Mouse | 0.82693795 |
| 152 | STAT3_23295773_ChIP-Seq_U87_Human | 0.82273192 |
| 153 | AR_19668381_ChIP-Seq_PC3_Human | 0.82189889 |
| 154 | UBF1/2_26484160_Chip-Seq_HMECs_Human | 0.81583241 |
| 155 | SMAD3_21741376_ChIP-Seq_ESCs_Human | 0.81490005 |
| 156 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.79327631 |
| 157 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.79327631 |
| 158 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.78303561 |
| 159 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.78239926 |
| 160 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 0.78215625 |
| 161 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.77867197 |
| 162 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 0.77093287 |
| 163 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.75012573 |
| 164 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.74980979 |
| 165 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.74004082 |
| 166 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.73541124 |
| 167 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.73534287 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 3.80318803 |
| 2 | MP0001958_emphysema | 3.69243711 |
| 3 | MP0004272_abnormal_basement_membrane | 3.47245119 |
| 4 | MP0003880_abnormal_central_pattern | 3.33877649 |
| 5 | MP0004270_analgesia | 2.98872181 |
| 6 | MP0003635_abnormal_synaptic_transmissio | 2.91810391 |
| 7 | MP0006054_spinal_hemorrhage | 2.91040285 |
| 8 | MP0003705_abnormal_hypodermis_morpholog | 2.71869808 |
| 9 | MP0005257_abnormal_intraocular_pressure | 2.65325098 |
| 10 | MP0002272_abnormal_nervous_system | 2.53952779 |
| 11 | MP0009046_muscle_twitch | 2.47740770 |
| 12 | MP0009745_abnormal_behavioral_response | 2.43969212 |
| 13 | MP0002064_seizures | 2.41965712 |
| 14 | MP0002254_reproductive_system_inflammat | 2.34533137 |
| 15 | MP0002734_abnormal_mechanical_nocicepti | 2.32150064 |
| 16 | MP0005645_abnormal_hypothalamus_physiol | 2.25576702 |
| 17 | MP0000013_abnormal_adipose_tissue | 2.24302034 |
| 18 | MP0001968_abnormal_touch/_nociception | 2.21634932 |
| 19 | MP0002063_abnormal_learning/memory/cond | 2.16198882 |
| 20 | MP0002822_catalepsy | 2.12657655 |
| 21 | MP0009384_cardiac_valve_regurgitation | 2.11988109 |
| 22 | MP0006276_abnormal_autonomic_nervous | 2.09405497 |
| 23 | MP0002736_abnormal_nociception_after | 2.08332934 |
| 24 | MP0005508_abnormal_skeleton_morphology | 2.07648441 |
| 25 | MP0002572_abnormal_emotion/affect_behav | 2.04450309 |
| 26 | MP0009780_abnormal_chondrocyte_physiolo | 2.00488486 |
| 27 | MP0001486_abnormal_startle_reflex | 1.99427753 |
| 28 | MP0010030_abnormal_orbit_morphology | 1.98863050 |
| 29 | MP0010368_abnormal_lymphatic_system | 1.96576672 |
| 30 | MP0003950_abnormal_plasma_membrane | 1.96310960 |
| 31 | MP0010386_abnormal_urinary_bladder | 1.87496875 |
| 32 | MP0002735_abnormal_chemical_nociception | 1.87320268 |
| 33 | MP0003787_abnormal_imprinting | 1.84167020 |
| 34 | MP0003122_maternal_imprinting | 1.84060682 |
| 35 | MP0002184_abnormal_innervation | 1.82618635 |
| 36 | MP0001970_abnormal_pain_threshold | 1.81219783 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.75205709 |
| 38 | MP0002733_abnormal_thermal_nociception | 1.72148607 |
| 39 | MP0002837_dystrophic_cardiac_calcinosis | 1.71253941 |
| 40 | MP0005023_abnormal_wound_healing | 1.70920354 |
| 41 | MP0001440_abnormal_grooming_behavior | 1.69903903 |
| 42 | MP0001501_abnormal_sleep_pattern | 1.69539034 |
| 43 | MP0008569_lethality_at_weaning | 1.64603963 |
| 44 | MP0000767_abnormal_smooth_muscle | 1.64419163 |
| 45 | MP0005503_abnormal_tendon_morphology | 1.63422648 |
| 46 | MP0002060_abnormal_skin_morphology | 1.61487005 |
| 47 | MP0002909_abnormal_adrenal_gland | 1.57937845 |
| 48 | MP0005423_abnormal_somatic_nervous | 1.57849473 |
| 49 | MP0003566_abnormal_cell_adhesion | 1.56907845 |
| 50 | MP0001905_abnormal_dopamine_level | 1.56851650 |
| 51 | MP0005646_abnormal_pituitary_gland | 1.56626923 |
| 52 | MP0001984_abnormal_olfaction | 1.56072297 |
| 53 | MP0004142_abnormal_muscle_tone | 1.55368399 |
| 54 | MP0008438_abnormal_cutaneous_collagen | 1.53279239 |
| 55 | MP0005670_abnormal_white_adipose | 1.51850269 |
| 56 | MP0004043_abnormal_pH_regulation | 1.49590271 |
| 57 | MP0002557_abnormal_social/conspecific_i | 1.49268528 |
| 58 | MP0001243_abnormal_dermal_layer | 1.48353006 |
| 59 | MP0002933_joint_inflammation | 1.48348127 |
| 60 | MP0005394_taste/olfaction_phenotype | 1.48156408 |
| 61 | MP0005499_abnormal_olfactory_system | 1.48156408 |
| 62 | MP0003879_abnormal_hair_cell | 1.45100495 |
| 63 | MP0003283_abnormal_digestive_organ | 1.44991855 |
| 64 | MP0004858_abnormal_nervous_system | 1.44596308 |
| 65 | MP0000955_abnormal_spinal_cord | 1.43603337 |
| 66 | MP0000751_myopathy | 1.43412299 |
| 67 | MP0001529_abnormal_vocalization | 1.40742186 |
| 68 | MP0004145_abnormal_muscle_electrophysio | 1.39156003 |
| 69 | MP0008789_abnormal_olfactory_epithelium | 1.36814865 |
| 70 | MP0003329_amyloid_beta_deposits | 1.36297141 |
| 71 | MP0000778_abnormal_nervous_system | 1.34925616 |
| 72 | MP0009840_abnormal_foam_cell | 1.33518690 |
| 73 | MP0005171_absent_coat_pigmentation | 1.32320245 |
| 74 | MP0002882_abnormal_neuron_morphology | 1.30166706 |
| 75 | MP0005390_skeleton_phenotype | 1.29353513 |
| 76 | MP0004742_abnormal_vestibular_system | 1.29273296 |
| 77 | MP0000538_abnormal_urinary_bladder | 1.28877311 |
| 78 | MP0001485_abnormal_pinna_reflex | 1.27221549 |
| 79 | MP0005623_abnormal_meninges_morphology | 1.26687782 |
| 80 | MP0001879_abnormal_lymphatic_vessel | 1.25721084 |
| 81 | MP0005058_abnormal_lysosome_morphology | 1.24926975 |
| 82 | MP0009250_abnormal_appendicular_skeleto | 1.23369248 |
| 83 | MP0000003_abnormal_adipose_tissue | 1.21931034 |
| 84 | MP0001502_abnormal_circadian_rhythm | 1.21698484 |
| 85 | MP0003186_abnormal_redox_activity | 1.20882486 |
| 86 | MP0005386_behavior/neurological_phenoty | 1.20485109 |
| 87 | MP0004924_abnormal_behavior | 1.20485109 |
| 88 | MP0002066_abnormal_motor_capabilities/c | 1.19272145 |
| 89 | MP0004885_abnormal_endolymph | 1.17447586 |
| 90 | MP0004811_abnormal_neuron_physiology | 1.15116620 |
| 91 | MP0002876_abnormal_thyroid_physiology | 1.14724227 |
| 92 | MP0002896_abnormal_bone_mineralization | 1.14698297 |
| 93 | MP0001188_hyperpigmentation | 1.13716344 |
| 94 | MP0006072_abnormal_retinal_apoptosis | 1.13674335 |
| 95 | MP0005377_hearing/vestibular/ear_phenot | 1.11880396 |
| 96 | MP0003878_abnormal_ear_physiology | 1.11880396 |
| 97 | MP0001963_abnormal_hearing_physiology | 1.11825951 |
| 98 | MP0000681_abnormal_thyroid_gland | 1.08585456 |
| 99 | MP0003634_abnormal_glial_cell | 1.07945453 |
| 100 | MP0000920_abnormal_myelination | 1.07624032 |
| 101 | MP0002229_neurodegeneration | 1.06971877 |
| 102 | MP0001542_abnormal_bone_strength | 1.06662764 |
| 103 | MP0000343_altered_response_to | 1.05788555 |
| 104 | MP0001756_abnormal_urination | 1.04825645 |
| 105 | MP0000750_abnormal_muscle_regeneration | 1.03798374 |
| 106 | MP0005164_abnormal_response_to | 1.01483858 |
| 107 | MP0003633_abnormal_nervous_system | 0.99616622 |
| 108 | MP0003091_abnormal_cell_migration | 0.97515853 |
| 109 | MP0000163_abnormal_cartilage_morphology | 0.96588658 |
| 110 | MP0001986_abnormal_taste_sensitivity | 0.95804125 |
| 111 | MP0002752_abnormal_somatic_nervous | 0.95102567 |
| 112 | MP0003011_delayed_dark_adaptation | 0.92742560 |
| 113 | MP0004085_abnormal_heartbeat | 0.89756941 |
| 114 | MP0001661_extended_life_span | 0.89509877 |
| 115 | MP0000631_abnormal_neuroendocrine_gland | 0.89352617 |
| 116 | MP0001348_abnormal_lacrimal_gland | 0.88505082 |
| 117 | MP0005165_increased_susceptibility_to | 0.88490832 |
| 118 | MP0001299_abnormal_eye_distance/ | 0.86308836 |
| 119 | MP0001664_abnormal_digestion | 0.84667077 |
| 120 | MP0003631_nervous_system_phenotype | 0.84174868 |
| 121 | MP0005551_abnormal_eye_electrophysiolog | 0.83772757 |
| 122 | MP0005275_abnormal_skin_tensile | 0.83532901 |
| 123 | MP0002115_abnormal_skeleton_extremities | 0.82108339 |
| 124 | MP0002877_abnormal_melanocyte_morpholog | 0.80788420 |
| 125 | MP0002152_abnormal_brain_morphology | 0.80412719 |
| 126 | MP0004510_myositis | 0.79522851 |
| 127 | MP0000026_abnormal_inner_ear | 0.79367419 |
| 128 | MP0000534_abnormal_ureter_morphology | 0.78307719 |
| 129 | MP0008775_abnormal_heart_ventricle | 0.76745654 |
| 130 | MP0003942_abnormal_urinary_system | 0.76692064 |
| 131 | MP0000762_abnormal_tongue_morphology | 0.76585457 |
| 132 | MP0001533_abnormal_skeleton_physiology | 0.75202425 |
| 133 | MP0000749_muscle_degeneration | 0.74376906 |
| 134 | MP0000462_abnormal_digestive_system | 0.73809681 |
| 135 | MP0003137_abnormal_impulse_conducting | 0.73792117 |
| 136 | MP0002638_abnormal_pupillary_reflex | 0.73554863 |
| 137 | MP0005375_adipose_tissue_phenotype | 0.73360043 |
| 138 | MP0005595_abnormal_vascular_smooth | 0.72746500 |
| 139 | MP0002069_abnormal_eating/drinking_beha | 0.72318212 |
| 140 | MP0005084_abnormal_gallbladder_morpholo | 0.71989129 |
| 141 | MP0004484_altered_response_of | 0.71634491 |
| 142 | MP0002751_abnormal_autonomic_nervous | 0.71294713 |
| 143 | MP0000759_abnormal_skeletal_muscle | 0.70908118 |
| 144 | MP0002295_abnormal_pulmonary_circulatio | 0.70220790 |
| 145 | MP0002108_abnormal_muscle_morphology | 0.70179548 |
| 146 | MP0000049_abnormal_middle_ear | 0.69441657 |
| 147 | MP0003279_aneurysm | 0.69238007 |
| 148 | MP0001944_abnormal_pancreas_morphology | 0.68503950 |
| 149 | MP0000230_abnormal_systemic_arterial | 0.68066518 |
| 150 | MP0000678_abnormal_parathyroid_gland | 0.67864343 |
| 151 | MP0002932_abnormal_joint_morphology | 0.66016998 |
| 152 | MP0002282_abnormal_trachea_morphology | 0.65393555 |
| 153 | MP0000604_amyloidosis | 0.64035829 |
| 154 | MP0003795_abnormal_bone_structure | 0.63456754 |
| 155 | MP0002113_abnormal_skeleton_development | 0.62524529 |
| 156 | MP0003448_altered_tumor_morphology | 0.62196937 |
| 157 | MP0002168_other_aberrant_phenotype | 0.61510361 |
| 158 | MP0005620_abnormal_muscle_contractility | 0.61320530 |
| 159 | MP0001881_abnormal_mammary_gland | 0.61310013 |
| 160 | MP0003075_altered_response_to | 0.60968133 |
| 161 | MP0001270_distended_abdomen | 0.60555120 |
| 162 | MP0005330_cardiomyopathy | 0.60312506 |
| 163 | MP0005360_urolithiasis | 0.59872353 |
| 164 | MP0000733_abnormal_muscle_development | 0.58860336 |
| 165 | MP0003191_abnormal_cellular_cholesterol | 0.57798461 |
| 166 | MP0010771_integument_phenotype | 0.56038286 |
| 167 | MP0005332_abnormal_amino_acid | 0.54622186 |
| 168 | MP0002128_abnormal_blood_circulation | 0.53048305 |
| 169 | MP0005369_muscle_phenotype | 0.50587729 |
| 170 | MP0005166_decreased_susceptibility_to | 0.49631068 |
| 171 | MP0001614_abnormal_blood_vessel | 0.48677867 |
| 172 | MP0008260_abnormal_autophagy | 0.46164402 |
| 173 | MP0000249_abnormal_blood_vessel | 0.45526379 |
| 174 | MP0000639_abnormal_adrenal_gland | 0.44453582 |
| 175 | MP0002133_abnormal_respiratory_system | 0.44248843 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Aortic aneurysm (HP:0004942) | 5.13146319 |
| 2 | Myokymia (HP:0002411) | 5.10951223 |
| 3 | Aortic dissection (HP:0002647) | 4.92680729 |
| 4 | Focal motor seizures (HP:0011153) | 4.70054440 |
| 5 | Atonic seizures (HP:0010819) | 4.40785456 |
| 6 | Follicular hyperkeratosis (HP:0007502) | 4.37081391 |
| 7 | Ankle contracture (HP:0006466) | 4.33411464 |
| 8 | Soft skin (HP:0000977) | 4.17100216 |
| 9 | Vertebral compression fractures (HP:0002953) | 4.06355007 |
| 10 | Vascular tortuosity (HP:0004948) | 4.03875540 |
| 11 | Type 1 muscle fiber predominance (HP:0003803) | 3.82959895 |
| 12 | Cervical subluxation (HP:0003308) | 3.81777510 |
| 13 | Bladder diverticulum (HP:0000015) | 3.80457062 |
| 14 | Focal seizures (HP:0007359) | 3.68265803 |
| 15 | Visual hallucinations (HP:0002367) | 3.68024597 |
| 16 | Acute necrotizing encephalopathy (HP:0006965) | 3.61614744 |
| 17 | Atrophic scars (HP:0001075) | 3.52105307 |
| 18 | Pheochromocytoma (HP:0002666) | 3.48331176 |
| 19 | Wormian bones (HP:0002645) | 3.43042821 |
| 20 | Abnormal mitochondria in muscle tissue (HP:0008316) | 3.28041433 |
| 21 | Spinal rigidity (HP:0003306) | 3.26101095 |
| 22 | Fragile skin (HP:0001030) | 3.25980736 |
| 23 | Genu recurvatum (HP:0002816) | 3.24937398 |
| 24 | Epileptic encephalopathy (HP:0200134) | 3.23281902 |
| 25 | Febrile seizures (HP:0002373) | 3.20685840 |
| 26 | Broad metatarsal (HP:0001783) | 3.20436272 |
| 27 | Slender build (HP:0001533) | 3.18767978 |
| 28 | Hypothermia (HP:0002045) | 3.15778172 |
| 29 | Joint stiffness (HP:0001387) | 3.10943200 |
| 30 | Blue sclerae (HP:0000592) | 3.09833986 |
| 31 | Neuroendocrine neoplasm (HP:0100634) | 3.08906251 |
| 32 | Progressive macrocephaly (HP:0004481) | 3.06757940 |
| 33 | Progressive cerebellar ataxia (HP:0002073) | 3.04588819 |
| 34 | Arterial tortuosity (HP:0005116) | 3.00319122 |
| 35 | Dilatation of the ascending aorta (HP:0005111) | 2.98150487 |
| 36 | Action tremor (HP:0002345) | 2.97006085 |
| 37 | Supranuclear gaze palsy (HP:0000605) | 2.89287073 |
| 38 | Absence seizures (HP:0002121) | 2.85696400 |
| 39 | Limb dystonia (HP:0002451) | 2.81912931 |
| 40 | Redundant skin (HP:0001582) | 2.76857321 |
| 41 | Mitochondrial inheritance (HP:0001427) | 2.74554016 |
| 42 | Anxiety (HP:0000739) | 2.74534905 |
| 43 | Acute encephalopathy (HP:0006846) | 2.73172876 |
| 44 | Retinal dysplasia (HP:0007973) | 2.73094872 |
| 45 | Neonatal short-limb short stature (HP:0008921) | 2.70050265 |
| 46 | Elevated circulating parathyroid hormone (PTH) level (HP:0003165) | 2.69237724 |
| 47 | Elbow flexion contracture (HP:0002987) | 2.67492772 |
| 48 | Bowel diverticulosis (HP:0005222) | 2.61961738 |
| 49 | Shallow orbits (HP:0000586) | 2.59734916 |
| 50 | Biconcave vertebral bodies (HP:0004586) | 2.59560898 |
| 51 | Dialeptic seizures (HP:0011146) | 2.58960213 |
| 52 | Hyperextensible skin (HP:0000974) | 2.56014624 |
| 53 | Generalized tonic-clonic seizures (HP:0002069) | 2.54658398 |
| 54 | Aortic regurgitation (HP:0001659) | 2.50718223 |
| 55 | Cerebral aneurysm (HP:0004944) | 2.48336115 |
| 56 | Nonimmune hydrops fetalis (HP:0001790) | 2.46749917 |
| 57 | Ankle clonus (HP:0011448) | 2.46094370 |
| 58 | Agitation (HP:0000713) | 2.43786105 |
| 59 | Mitral stenosis (HP:0001718) | 2.43733773 |
| 60 | Joint laxity (HP:0001388) | 2.43690601 |
| 61 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.43477527 |
| 62 | Peritonitis (HP:0002586) | 2.43402826 |
| 63 | Bradycardia (HP:0001662) | 2.42521106 |
| 64 | Wrist flexion contracture (HP:0001239) | 2.40780030 |
| 65 | Gait imbalance (HP:0002141) | 2.40363044 |
| 66 | Infantile muscular hypotonia (HP:0008947) | 2.37600478 |
| 67 | Medial flaring of the eyebrow (HP:0010747) | 2.37223966 |
| 68 | Spondylolisthesis (HP:0003302) | 2.36311478 |
| 69 | Abnormality of dentin (HP:0010299) | 2.33719790 |
| 70 | Aortic valve stenosis (HP:0001650) | 2.33164293 |
| 71 | Delayed gross motor development (HP:0002194) | 2.32658850 |
| 72 | Generalized amyotrophy (HP:0003700) | 2.29990000 |
| 73 | Abnormal delivery (HP:0001787) | 2.29480135 |
| 74 | Abnormality of calcium-phosphate metabolism (HP:0100530) | 2.29163781 |
| 75 | Coronal craniosynostosis (HP:0004440) | 2.29127778 |
| 76 | Hypoventilation (HP:0002791) | 2.26154439 |
| 77 | Upper limb amyotrophy (HP:0009129) | 2.25622934 |
| 78 | Distal upper limb amyotrophy (HP:0007149) | 2.25622934 |
| 79 | Pulmonary artery stenosis (HP:0004415) | 2.25206499 |
| 80 | Stridor (HP:0010307) | 2.23915851 |
| 81 | Scanning speech (HP:0002168) | 2.21878587 |
| 82 | Congenital primary aphakia (HP:0007707) | 2.20477222 |
| 83 | Hypercortisolism (HP:0001578) | 2.20250568 |
| 84 | Ovoid vertebral bodies (HP:0003300) | 2.19408426 |
| 85 | Ulnar deviation of the wrist (HP:0003049) | 2.18249623 |
| 86 | Cardiovascular calcification (HP:0011915) | 2.18213605 |
| 87 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.16682021 |
| 88 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.16682021 |
| 89 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.16682021 |
| 90 | Hepatocellular necrosis (HP:0001404) | 2.15939324 |
| 91 | Truncal ataxia (HP:0002078) | 2.15887522 |
| 92 | Aneurysm (HP:0002617) | 2.14805691 |
| 93 | Hand muscle atrophy (HP:0009130) | 2.14015158 |
| 94 | Narrow nasal bridge (HP:0000446) | 2.13583075 |
| 95 | Myotonia (HP:0002486) | 2.12100435 |
| 96 | Depression (HP:0000716) | 2.11857504 |
| 97 | Hyperparathyroidism (HP:0000843) | 2.11307485 |
| 98 | Ulnar bowing (HP:0003031) | 2.11165077 |
| 99 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.10835386 |
| 100 | Mucopolysacchariduria (HP:0008155) | 2.10835386 |
| 101 | Wide anterior fontanel (HP:0000260) | 2.10741026 |
| 102 | Dysmetria (HP:0001310) | 2.08467377 |
| 103 | Neurofibrillary tangles (HP:0002185) | 2.07501142 |
| 104 | Abnormal eating behavior (HP:0100738) | 2.04115907 |
| 105 | Aplasia/Hypoplasia of the lens (HP:0008063) | 2.04056894 |
| 106 | Round ear (HP:0100830) | 2.03818550 |
| 107 | Hypoplasia of the odontoid process (HP:0003311) | 2.03443843 |
| 108 | Hydroureter (HP:0000072) | 2.03042483 |
| 109 | Increased CSF lactate (HP:0002490) | 2.02652070 |
| 110 | Mild short stature (HP:0003502) | 2.02212286 |
| 111 | Foot dorsiflexor weakness (HP:0009027) | 2.01164161 |
| 112 | Leukodystrophy (HP:0002415) | 2.00232789 |
| 113 | Osteolytic defects of the hand bones (HP:0009699) | 1.98516358 |
| 114 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.98516358 |
| 115 | Failure to thrive in infancy (HP:0001531) | 1.98000455 |
| 116 | Nephrogenic diabetes insipidus (HP:0009806) | 1.96531477 |
| 117 | Genital tract atresia (HP:0001827) | 1.96484142 |
| 118 | Vaginal atresia (HP:0000148) | 1.96312366 |
| 119 | Mitral regurgitation (HP:0001653) | 1.96282777 |
| 120 | Abnormality of proline metabolism (HP:0010907) | 1.96193197 |
| 121 | Hydroxyprolinuria (HP:0003080) | 1.96193197 |
| 122 | Ectopia lentis (HP:0001083) | 1.96012062 |
| 123 | Long toe (HP:0010511) | 1.95738092 |
| 124 | Premature skin wrinkling (HP:0100678) | 1.95362304 |
| 125 | Short nail (HP:0001799) | 1.94149816 |
| 126 | Dysostosis multiplex (HP:0000943) | 1.93276746 |
| 127 | Gaze-evoked nystagmus (HP:0000640) | 1.93050248 |
| 128 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.92351928 |
| 129 | Reduced subcutaneous adipose tissue (HP:0003758) | 1.91950914 |
| 130 | Prolonged QT interval (HP:0001657) | 1.90100625 |
| 131 | Mesomelia (HP:0003027) | 1.89496768 |
| 132 | Anosmia (HP:0000458) | 1.89395857 |
| 133 | Emphysema (HP:0002097) | 1.87705282 |
| 134 | Postural tremor (HP:0002174) | 1.87083749 |
| 135 | Nuclear cataract (HP:0100018) | 1.87038673 |
| 136 | Hemiparesis (HP:0001269) | 1.86749622 |
| 137 | Amblyopia (HP:0000646) | 1.85574450 |
| 138 | Distal lower limb muscle weakness (HP:0009053) | 1.85446982 |
| 139 | Glucose intolerance (HP:0000833) | 1.85137686 |
| 140 | Mitral valve prolapse (HP:0001634) | 1.82950113 |
| 141 | Premature rupture of membranes (HP:0001788) | 1.81653897 |
| 142 | Testicular atrophy (HP:0000029) | 1.81524291 |
| 143 | Abnormality of the odontoid process (HP:0003310) | 1.81223136 |
| 144 | Epileptiform EEG discharges (HP:0011182) | 1.81185555 |
| 145 | Increased connective tissue (HP:0009025) | 1.81135278 |
| 146 | Broad-based gait (HP:0002136) | 1.80915794 |
| 147 | Abnormality of the acetabulum (HP:0003170) | 1.80077134 |
| 148 | Ulnar claw (HP:0001178) | 1.79506290 |
| 149 | Osteoarthritis (HP:0002758) | 1.78810828 |
| 150 | Abnormality of the foot musculature (HP:0001436) | 1.78548749 |
| 151 | Torticollis (HP:0000473) | 1.78360509 |
| 152 | Optic disc pallor (HP:0000543) | 1.77757599 |
| 153 | EEG with generalized epileptiform discharges (HP:0011198) | 1.77546606 |
| 154 | Spinal cord compression (HP:0002176) | 1.77091295 |
| 155 | Split foot (HP:0001839) | 1.76977625 |
| 156 | Atelectasis (HP:0100750) | 1.76289317 |
| 157 | Delusions (HP:0000746) | 1.76162569 |
| 158 | Abnormality of glycolipid metabolism (HP:0010969) | 1.75894688 |
| 159 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.75894688 |
| 160 | Abnormality of binocular vision (HP:0011514) | 1.74920958 |
| 161 | Diplopia (HP:0000651) | 1.74920958 |
| 162 | Hyperventilation (HP:0002883) | 1.74513019 |
| 163 | Adrenal overactivity (HP:0002717) | 1.74414068 |
| 164 | Cerebral inclusion bodies (HP:0100314) | 1.74370051 |
| 165 | Abnormal hair whorl (HP:0010721) | 1.71471628 |
| 166 | Hypsarrhythmia (HP:0002521) | 1.70580618 |
| 167 | Spinal canal stenosis (HP:0003416) | 1.69711037 |
| 168 | Dysdiadochokinesis (HP:0002075) | 1.69647302 |
| 169 | Decreased circulating renin level (HP:0003351) | 1.68805591 |
| 170 | Psychosis (HP:0000709) | 1.67749886 |
| 171 | Congenital glaucoma (HP:0001087) | 1.65458878 |
| 172 | Protrusio acetabuli (HP:0003179) | 1.65382121 |
| 173 | Focal dystonia (HP:0004373) | 1.65242885 |
| 174 | Spastic gait (HP:0002064) | 1.64299224 |
| 175 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.63909476 |
| 176 | Specific learning disability (HP:0001328) | 1.63840769 |
| 177 | Palpebral edema (HP:0100540) | 1.63050555 |
| 178 | Hepatic necrosis (HP:0002605) | 1.61699906 |
| 179 | Abnormality of magnesium homeostasis (HP:0004921) | 1.58918428 |
| 180 | Craniofacial dystonia (HP:0012179) | 1.58727152 |
| 181 | Increased circulating renin level (HP:0000848) | 1.58197930 |
| 182 | Megalencephaly (HP:0001355) | 1.58124162 |
| 183 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 1.57633606 |
| 184 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 1.57633606 |
| 185 | Polyphagia (HP:0002591) | 1.57612810 |
| 186 | Neoplasm of the peripheral nervous system (HP:0100007) | 1.57379759 |
| 187 | Respiratory failure (HP:0002878) | 1.56980484 |
| 188 | Increased variability in muscle fiber diameter (HP:0003557) | 1.55959614 |
| 189 | Oligomenorrhea (HP:0000876) | 1.54666068 |
| 190 | Cortical visual impairment (HP:0100704) | 1.54560841 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | NTRK3 | 3.30969059 |
| 2 | CASK | 3.04064152 |
| 3 | ARAF | 2.52069593 |
| 4 | ERN1 | 2.51921067 |
| 5 | EPHB2 | 2.43811054 |
| 6 | INSRR | 2.33593634 |
| 7 | MAP3K4 | 2.31921998 |
| 8 | MAP2K7 | 2.25485762 |
| 9 | BMPR2 | 2.12914157 |
| 10 | CAMKK2 | 2.09520640 |
| 11 | MAPKAPK3 | 2.08837910 |
| 12 | MAPK15 | 2.03941044 |
| 13 | ERBB3 | 2.00318084 |
| 14 | NTRK1 | 1.99759492 |
| 15 | MINK1 | 1.98621261 |
| 16 | ABL2 | 1.98515504 |
| 17 | PDGFRA | 1.95861922 |
| 18 | WNK4 | 1.84011011 |
| 19 | STK39 | 1.80589095 |
| 20 | MAP3K3 | 1.80011425 |
| 21 | MAP3K12 | 1.79025307 |
| 22 | PIM2 | 1.77996784 |
| 23 | PAK2 | 1.74669328 |
| 24 | LIMK1 | 1.73018775 |
| 25 | NME2 | 1.66817156 |
| 26 | GRK5 | 1.66064826 |
| 27 | ILK | 1.63538168 |
| 28 | PLK2 | 1.62541572 |
| 29 | OXSR1 | 1.62396502 |
| 30 | GRK1 | 1.60879499 |
| 31 | PRKD3 | 1.58146910 |
| 32 | MAP3K9 | 1.54795755 |
| 33 | PIK3CG | 1.54563163 |
| 34 | TGFBR2 | 1.54049591 |
| 35 | MAPKAPK5 | 1.49262546 |
| 36 | DDR2 | 1.46338731 |
| 37 | UHMK1 | 1.44599041 |
| 38 | EPHA4 | 1.42596160 |
| 39 | STK38 | 1.41607995 |
| 40 | PHKG1 | 1.40388707 |
| 41 | PHKG2 | 1.40388707 |
| 42 | PAK4 | 1.39195430 |
| 43 | CDK19 | 1.35954688 |
| 44 | CAMK2B | 1.34878178 |
| 45 | CAMK2D | 1.34538836 |
| 46 | NTRK2 | 1.33174064 |
| 47 | TTN | 1.32459612 |
| 48 | WNK1 | 1.32108854 |
| 49 | MARK1 | 1.30691784 |
| 50 | MAP2K4 | 1.30261608 |
| 51 | BCKDK | 1.30015532 |
| 52 | EPHA2 | 1.27969731 |
| 53 | MYLK | 1.25934085 |
| 54 | MUSK | 1.25852275 |
| 55 | NME1 | 1.19568712 |
| 56 | BCR | 1.19016353 |
| 57 | MAPK13 | 1.18673248 |
| 58 | FLT3 | 1.18278621 |
| 59 | KSR2 | 1.15874198 |
| 60 | CDK5 | 1.15057634 |
| 61 | PRKG2 | 1.14600656 |
| 62 | MAP3K2 | 1.13147978 |
| 63 | ROCK1 | 1.11793832 |
| 64 | PAK3 | 1.10554092 |
| 65 | CAMK2A | 1.10446670 |
| 66 | CAMK2G | 1.09526704 |
| 67 | DAPK2 | 1.09228659 |
| 68 | CAMKK1 | 1.09069434 |
| 69 | PAK6 | 1.08644033 |
| 70 | FER | 1.08327887 |
| 71 | SGK494 | 1.07741738 |
| 72 | SGK223 | 1.07741738 |
| 73 | PRKCE | 1.05179391 |
| 74 | PRKCG | 1.01968687 |
| 75 | PTK2B | 1.01916944 |
| 76 | PRPF4B | 1.00006947 |
| 77 | STK16 | 0.99087528 |
| 78 | CSNK1G2 | 0.95901590 |
| 79 | CDK14 | 0.95488772 |
| 80 | CSNK1G3 | 0.92349225 |
| 81 | BRAF | 0.91568087 |
| 82 | SIK1 | 0.86384381 |
| 83 | FRK | 0.85833357 |
| 84 | CDK18 | 0.85368842 |
| 85 | DAPK3 | 0.85252702 |
| 86 | SIK2 | 0.85145658 |
| 87 | EPHB1 | 0.84221324 |
| 88 | PNCK | 0.84137467 |
| 89 | CDK15 | 0.83191340 |
| 90 | CDC42BPA | 0.82312947 |
| 91 | TNIK | 0.81301093 |
| 92 | TAOK2 | 0.81250540 |
| 93 | TESK1 | 0.79680702 |
| 94 | SIK3 | 0.77985502 |
| 95 | GSK3A | 0.77658632 |
| 96 | PAK1 | 0.77257660 |
| 97 | MAP3K11 | 0.75988558 |
| 98 | CDK11A | 0.73140212 |
| 99 | PRKCH | 0.73020111 |
| 100 | MAP2K1 | 0.72961397 |
| 101 | PIK3CA | 0.72344395 |
| 102 | DMPK | 0.71724859 |
| 103 | GRK7 | 0.71478654 |
| 104 | TESK2 | 0.71008836 |
| 105 | PKN1 | 0.70897574 |
| 106 | TYK2 | 0.67771979 |
| 107 | MET | 0.67463380 |
| 108 | CSNK1A1L | 0.67332475 |
| 109 | ROCK2 | 0.66902992 |
| 110 | LMTK2 | 0.66281880 |
| 111 | MAP3K6 | 0.66265761 |
| 112 | NEK6 | 0.64936778 |
| 113 | HIPK2 | 0.64848235 |
| 114 | PKN2 | 0.63380647 |
| 115 | TBK1 | 0.63005414 |
| 116 | AKT3 | 0.62064684 |
| 117 | RET | 0.62015269 |
| 118 | WNK3 | 0.61528984 |
| 119 | ADRBK1 | 0.60443919 |
| 120 | TNK2 | 0.60328580 |
| 121 | MAP4K2 | 0.59020268 |
| 122 | MAP3K1 | 0.58953976 |
| 123 | TRPM7 | 0.57005250 |
| 124 | DAPK1 | 0.56990747 |
| 125 | TIE1 | 0.56663890 |
| 126 | MARK2 | 0.55517876 |
| 127 | CAMK1 | 0.55124673 |
| 128 | IRAK3 | 0.55006027 |
| 129 | PRKD2 | 0.54975624 |
| 130 | MOS | 0.54915793 |
| 131 | IRAK2 | 0.54376650 |
| 132 | TRIB3 | 0.52888371 |
| 133 | ADRBK2 | 0.51261696 |
| 134 | EPHA3 | 0.50653646 |
| 135 | DYRK1A | 0.50512495 |
| 136 | KIT | 0.50173833 |
| 137 | CSNK1G1 | 0.48910024 |
| 138 | LATS2 | 0.48909807 |
| 139 | JAK1 | 0.47224763 |
| 140 | PRKCI | 0.46460811 |
| 141 | PRKACA | 0.46231811 |
| 142 | PRKD1 | 0.45656080 |
| 143 | PDGFRB | 0.45268242 |
| 144 | RIPK1 | 0.44840149 |
| 145 | BMPR1B | 0.44668550 |
| 146 | MAPK7 | 0.42598151 |
| 147 | PTK2 | 0.40966503 |
| 148 | RPS6KA2 | 0.35357216 |
| 149 | MAP2K6 | 0.34569185 |
| 150 | MAPK4 | 0.33492089 |
| 151 | NEK9 | 0.32965102 |
| 152 | MAP3K13 | 0.32574873 |
| 153 | BRSK1 | 0.30086375 |
| 154 | PINK1 | 0.27836025 |
| 155 | SRC | 0.27089279 |
| 156 | PDK2 | 0.26898134 |
| 157 | PRKCD | 0.26627186 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 3.11375860 |
| 2 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.98249362 |
| 3 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.84433808 |
| 4 | ECM-receptor interaction_Homo sapiens_hsa04512 | 2.78821363 |
| 5 | Nicotine addiction_Homo sapiens_hsa05033 | 2.65039913 |
| 6 | Sulfur relay system_Homo sapiens_hsa04122 | 2.57347492 |
| 7 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 2.51061873 |
| 8 | Parkinsons disease_Homo sapiens_hsa05012 | 2.31788943 |
| 9 | GABAergic synapse_Homo sapiens_hsa04727 | 2.31030466 |
| 10 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.28864093 |
| 11 | Olfactory transduction_Homo sapiens_hsa04740 | 2.28335313 |
| 12 | Other glycan degradation_Homo sapiens_hsa00511 | 2.25877133 |
| 13 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 2.23693092 |
| 14 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 2.19807121 |
| 15 | Circadian entrainment_Homo sapiens_hsa04713 | 2.18931051 |
| 16 | Insulin secretion_Homo sapiens_hsa04911 | 2.16321338 |
| 17 | Taste transduction_Homo sapiens_hsa04742 | 2.10848045 |
| 18 | Alzheimers disease_Homo sapiens_hsa05010 | 2.07047378 |
| 19 | Morphine addiction_Homo sapiens_hsa05032 | 2.00010323 |
| 20 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.98420283 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.96282083 |
| 22 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.95117175 |
| 23 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 1.94362353 |
| 24 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.86922889 |
| 25 | Protein export_Homo sapiens_hsa03060 | 1.86297317 |
| 26 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.85062156 |
| 27 | Focal adhesion_Homo sapiens_hsa04510 | 1.81910227 |
| 28 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.79477631 |
| 29 | Cocaine addiction_Homo sapiens_hsa05030 | 1.76085092 |
| 30 | Long-term potentiation_Homo sapiens_hsa04720 | 1.75779191 |
| 31 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.74174630 |
| 32 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 1.68645420 |
| 33 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.67247024 |
| 34 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.57116811 |
| 35 | Salivary secretion_Homo sapiens_hsa04970 | 1.56889896 |
| 36 | Proteasome_Homo sapiens_hsa03050 | 1.56850862 |
| 37 | Huntingtons disease_Homo sapiens_hsa05016 | 1.56850725 |
| 38 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.55555487 |
| 39 | Long-term depression_Homo sapiens_hsa04730 | 1.48666511 |
| 40 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.38306247 |
| 41 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.36812358 |
| 42 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.36529816 |
| 43 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.35937805 |
| 44 | Galactose metabolism_Homo sapiens_hsa00052 | 1.22911187 |
| 45 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.21005066 |
| 46 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.19115713 |
| 47 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.18381520 |
| 48 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.16897092 |
| 49 | Gap junction_Homo sapiens_hsa04540 | 1.15174086 |
| 50 | Renin secretion_Homo sapiens_hsa04924 | 1.13434509 |
| 51 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.12807842 |
| 52 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.10058869 |
| 53 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.07090070 |
| 54 | Pancreatic secretion_Homo sapiens_hsa04972 | 1.04668176 |
| 55 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.03982433 |
| 56 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.03952648 |
| 57 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.03917094 |
| 58 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.02698116 |
| 59 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 1.01961248 |
| 60 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.01022819 |
| 61 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.97255815 |
| 62 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.96038790 |
| 63 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.95962699 |
| 64 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.88419276 |
| 65 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.87182233 |
| 66 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87169558 |
| 67 | Amoebiasis_Homo sapiens_hsa05146 | 0.86923585 |
| 68 | Phototransduction_Homo sapiens_hsa04744 | 0.86314545 |
| 69 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.85556508 |
| 70 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.84218138 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.83680615 |
| 72 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.83276894 |
| 73 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.82993438 |
| 74 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.82787226 |
| 75 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.82287918 |
| 76 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.81596827 |
| 77 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.81445399 |
| 78 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.81124272 |
| 79 | Melanogenesis_Homo sapiens_hsa04916 | 0.80756925 |
| 80 | Axon guidance_Homo sapiens_hsa04360 | 0.80677597 |
| 81 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.78454803 |
| 82 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.77874427 |
| 83 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.76698521 |
| 84 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.74774917 |
| 85 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 0.74420058 |
| 86 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.74263226 |
| 87 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.73924269 |
| 88 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.73300982 |
| 89 | PI3K-Akt signaling pathway_Homo sapiens_hsa04151 | 0.71454178 |
| 90 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.69791550 |
| 91 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.68875467 |
| 92 | Pertussis_Homo sapiens_hsa05133 | 0.67429035 |
| 93 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.66921504 |
| 94 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.64249963 |
| 95 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.63008453 |
| 96 | Phagosome_Homo sapiens_hsa04145 | 0.62313549 |
| 97 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.61985913 |
| 98 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.61353939 |
| 99 | Alcoholism_Homo sapiens_hsa05034 | 0.61101085 |
| 100 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.60773338 |
| 101 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.59242163 |
| 102 | Malaria_Homo sapiens_hsa05144 | 0.57175020 |
| 103 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.56562630 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.56303199 |
| 105 | Circadian rhythm_Homo sapiens_hsa04710 | 0.55412973 |
| 106 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.55377191 |
| 107 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.54414209 |
| 108 | Glioma_Homo sapiens_hsa05214 | 0.53146307 |
| 109 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.52032868 |
| 110 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.51790952 |
| 111 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.51310303 |
| 112 | Melanoma_Homo sapiens_hsa05218 | 0.50369915 |
| 113 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.49170823 |
| 114 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.49130699 |
| 115 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.48828374 |
| 116 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.48334298 |
| 117 | Metabolic pathways_Homo sapiens_hsa01100 | 0.47960554 |
| 118 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 0.47091081 |
| 119 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.46953743 |
| 120 | Prion diseases_Homo sapiens_hsa05020 | 0.46220836 |
| 121 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.45461715 |
| 122 | Lysosome_Homo sapiens_hsa04142 | 0.44575293 |
| 123 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.43703359 |
| 124 | Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 0.43629669 |
| 125 | Mineral absorption_Homo sapiens_hsa04978 | 0.43538269 |
| 126 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.43407234 |
| 127 | Peroxisome_Homo sapiens_hsa04146 | 0.43306855 |
| 128 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.43206228 |
| 129 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.42966916 |
| 130 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.42592324 |
| 131 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.42574341 |
| 132 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.41907233 |
| 133 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.41027617 |
| 134 | Other types of O-glycan biosynthesis_Homo sapiens_hsa00514 | 0.40229814 |
| 135 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.39518765 |
| 136 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.39230049 |
| 137 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.38974143 |
| 138 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.38628513 |
| 139 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.38344252 |
| 140 | Tight junction_Homo sapiens_hsa04530 | 0.37336774 |
| 141 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.36556489 |
| 142 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.36413845 |
| 143 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.35411595 |
| 144 | Shigellosis_Homo sapiens_hsa05131 | 0.34559086 |
| 145 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.34356404 |
| 146 | Endocytosis_Homo sapiens_hsa04144 | 0.32993370 |
| 147 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.31287894 |
| 148 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.30667476 |
| 149 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.29573701 |

